Oral phenytoin pharmacokinetics during omeprazole therapy. 1987

P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
Department of Therapeutics, University Hospital, Nottingham.

1. In a double-blind crossover study 10 healthy males received either placebo or omeprazole (40 mg day-1) for 9 days, a single dose of phenytoin (300 mg) being taken on the seventh day. 2. Omeprazole significantly increased the area under the curve (0 to 72 h) of phenytoin (mean +/- s.e. mean) from 121.6 +/- 14.0 to 151.4 +/- 13.6 micrograms ml-1 h) (P less than 0.01). 3. The peak concentration, and apparent elimination half-life of phenytoin also tended to be increased though not significantly. 4. The omeprazole-phenytoin interaction observed may be clinically important because of the low therapeutic index associated with phenytoin.

UI MeSH Term Description Entries
D008297 Male Males
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
January 1984, European journal of clinical pharmacology,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
December 2005, Journal of veterinary pharmacology and therapeutics,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
November 1988, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
January 1978, Padiatrie und Grenzgebiete,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
October 1993, Critical care medicine,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
April 1999, Epilepsy research,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
February 1991, The New England journal of medicine,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
January 1984, European journal of clinical pharmacology,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
March 1997, Journal of the neurological sciences,
P J Prichard, and R P Walt, and G K Kitchingman, and K W Somerville, and M J Langman, and J Williams, and A Richens
July 2002, Epilepsia,
Copied contents to your clipboard!